15290
Urolithiasis takes one of the first plac¬es in the structure of urological diseas¬es. Kidney and urinary tract stones are detected in 30-45% of patients admit¬ted to urological hospitals.
32542
Cernilton® Efficiency and Safety in Treatment of Patients with Chronic Abacterial Prostatitis and BPH Evaluation Recent A.V. Sivkov, D.A. Bedretdinova Cernilton® is a medication which active components are microbiologically fermented pollen extract of various plants. Medicine has antiedemic and anti-inflammatory activity, capable to inhibit 5-а reductase thus slowing down prostate cells proliferation. Also improves voiding by а-1 receptors blocking and direct relaxation activity on urethral smooth muscles.
31997
The author presented results of the clinical study on efficacy and safety of alpha1-adrenoreceptor antagonist Tulosin (produced by «Egis») as a single agent therapy in patients with benign prostatic hyperplasia (BPH). The research team included 30 patients aged 50 to 82 years. Inclusion criteria – patients with BPH, expressiveness symptoms on a scale International Prostate Symptom Score (IPSS) more 9 points, the volume of residual urine not more than 100 ml. Treatment was conducted within 2 months, with compulsory monitoring of patient every month.
